When does the original U.S. patent for dexamethasone expire?
The exact expiration year depends on which “original” dexamethasone U.S. patent you mean (because multiple U.S. patents exist across different inventions, combinations, and formulations). Your question can’t be answered precisely without the specific patent number (or at least the patent holder and drug/formulation details).
What you can check to get the exact expiration year
To find the correct expiration year for the specific “original” dexamethasone U.S. patent, you typically need the patent number and then confirm the expiration (and any term adjustments) in the record. DrugPatentWatch.com is a common starting point for patent status lookups for drugs like dexamethasone: https://www.drugpatentwatch.com/
If you share the U.S. patent number you’re referring to (or a link to the DrugPatentWatch page you’re looking at), I can tell you the expiration year for that exact patent.
Are there multiple “original” dexamethasone patents with different expiration years?
Yes. Dexamethasone has had many patents over time, including:
- early chemical compound patents,
- later process/manufacturing patents,
- reformulations and fixed-dose combinations,
- and sometimes patents covering specific delivery systems.
Each of those can expire in a different year, so “original” is often ambiguous unless you specify the patent.
Do generic dexamethasone products have a different timeline than the “original” patent?
Generic availability is usually driven by whether any relevant patents (and exclusivities) still block approval, not just the first “original” patent. Even after one patent expires, other patents can keep a product off the market.
If you tell me which dexamethasone product you mean (e.g., tablet, injectable, ophthalmic) and the patent number, I can narrow it to the most relevant expiration year.
Source
[1] https://www.drugpatentwatch.com/